ConductScience.org, home

Paper8996540

Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature.

Fazeny B and 9 others. J Cancer Res Clin Oncol, 1997. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature. Papers, record 8996540. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8996540

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1997
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2025-07-19
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fazeny BB
2Baur MM
3Prohaska MM
4Hudec MM
5Kremnitzer MM
6Meryn SS
7Huber HH
8Grunt TT
9Tuchmann AA
10Dittrich CC

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, HormonalMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Pancreatic NeoplasmsMajor topic
Aged
Female
Goserelin
Humans
Male
Middle Aged
Neoplasm Staging
Octreotide
Pilot Projects

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16141560Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6141560PubMed
21346097Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study.Cancer1992https://conductscience.org/library/papers/1346097PubMed
31977468Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.Br J Cancer1990https://conductscience.org/library/papers/1977468PubMed
42573055Membrane receptors for peptides in experimental and human pancreatic cancers.Pancreas1989https://conductscience.org/library/papers/2573055PubMed
52300842Sandostatin-induced thrombocytopenia.South Med J1990https://conductscience.org/library/papers/2300842PubMed
67804972Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas.Cancer1995https://conductscience.org/library/papers/7804972PubMed
78532003Octreotide.N Engl J Med1996https://conductscience.org/library/papers/8532003PubMed
81513800Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin.Pancreas1992https://conductscience.org/library/papers/1513800PubMed
92871684Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration.Acta Endocrinol (Copenh)1986https://conductscience.org/library/papers/2871684PubMed
102567204Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.Cancer Lett1989https://conductscience.org/library/papers/2567204PubMed
117819058A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.Br J Cancer1995https://conductscience.org/library/papers/7819058PubMed
123955505Androgen receptor in human normal and malignant pancreatic tissue and cell lines.Cancer1986https://conductscience.org/library/papers/3955505PubMed
137459811Reporting results of cancer treatment.Cancer1981https://conductscience.org/library/papers/7459811PubMed
147786820Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study.Ann Oncol1995https://conductscience.org/library/papers/7786820PubMed
156128648SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.Life Sci1982https://conductscience.org/library/papers/6128648PubMed
166791734Oestrogen receptor proteins in malignant and fetal pancreas.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6791734PubMed
172659684Androgen influence on exocrine pancreatic cancer.Int J Pancreatol1989https://conductscience.org/library/papers/2659684PubMed
188373420Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype.Biochem Biophys Res Commun1993https://conductscience.org/library/papers/8373420PubMed
198204534Multimodality treatment of locally advanced pancreatic cancer.Ann Oncol1994https://conductscience.org/library/papers/8204534PubMed
208302789Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer.Pancreas1993https://conductscience.org/library/papers/8302789PubMed

See all 32 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
31451931Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.J Cancer Res Clin Oncol2019https://conductscience.org/library/papers/31451931PubMed
23667314A review of the use of somatostatin analogs in oncology.Onco Targets Ther2013https://conductscience.org/library/papers/23667314PubMed
22529684Adjuvant and neoadjuvant treatment in pancreatic cancer.World J Gastroenterol2012https://conductscience.org/library/papers/22529684PubMed
19521786Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster.Clin Exp Metastasis2009https://conductscience.org/library/papers/19521786PubMed
14688834Pancreatic cancer - a continuing challenge in oncology.Pathol Oncol Res2003https://conductscience.org/library/papers/14688834PubMed
10852640Pancreatic cancer: a review of emerging therapies.Drugs2000https://conductscience.org/library/papers/10852640PubMed
9951952Practical recommendations for the management of adenocarcinoma of the pancreas.Drugs1999https://conductscience.org/library/papers/9951952PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8996540

GET https://conductscience.org/api/papers/v1/8996540/references?page=2